Parker-Hannifin Corp 8-K

What Happened On March 13, 2026, Parker-Hannifin Corporation announced in an 8-K that Director Kevin A. Lobo has notified the company he will not stand for re-election to the Board of Directors at the Company’s 2026 Annual Meeting of Shareholders. Mr. Lobo has served on the board since 2013 and said his decision is a result of his election to the Board of Directors of GE HealthCare Technologies Inc. The company stated his decision was not due to any disagreement with Parker-Hannifin’s operations, policies or practices. Mr. Lobo is expected to continue serving as a director until the expiration of his current term.

Key Details

• Filing: Form 8-K (Item 5.02) filed March 17, 2026 reporting the notice given March 13, 2026.
• Director tenure: Kevin A. Lobo has served as a Parker-Hannifin director since 2013.
• Reason: He will not seek re-election due to his election to the GE HealthCare Technologies Inc. board.
• No dispute: The departure is not the result of any disagreement with the company’s operations, policies or practices.

Why It Matters A board member with over a decade of service will not stand for re-election, which affects Parker-Hannifin’s board composition and upcoming director slate for the 2026 annual meeting. The filing signals an orderly change — Mr. Lobo will remain through his current term and the company reports no disagreement — so investors should view this as a routine board transition rather than a governance dispute. Investors tracking board experience, governance, or potential committee changes may want to watch the company’s proxy materials for the final 2026 director slate and any related governance updates.